Angus Bell

3.2k total citations
62 papers, 2.5k citations indexed

About

Angus Bell is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Angus Bell has authored 62 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 32 papers in Public Health, Environmental and Occupational Health and 13 papers in Oncology. Recurrent topics in Angus Bell's work include Malaria Research and Control (27 papers), Signaling Pathways in Disease (16 papers) and Trypanosoma species research and implications (12 papers). Angus Bell is often cited by papers focused on Malaria Research and Control (27 papers), Signaling Pathways in Disease (16 papers) and Trypanosoma species research and implications (12 papers). Angus Bell collaborates with scholars based in Ireland, Canada and United States. Angus Bell's co-authors include Robert E. W. Hancock, John Walsh, Paul Monaghan, Richard M. Franklin, Mark A. Hermodson, Julie Naughton, Antony P. Page, James M. Groarke, James Hope and Brian J. Fennell and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Angus Bell

62 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angus Bell Ireland 29 1.3k 795 382 361 359 62 2.5k
Heinrich C. Hoppe South Africa 30 891 0.7× 925 1.2× 144 0.4× 498 1.4× 616 1.7× 132 2.9k
Ann E. Eakin United States 25 1.1k 0.9× 453 0.6× 146 0.4× 930 2.6× 284 0.8× 50 2.2k
Paul F. G. Sims United Kingdom 39 1.8k 1.4× 1.8k 2.3× 235 0.6× 975 2.7× 202 0.6× 106 4.5k
Vincenzo Enea United States 27 1.3k 1.0× 1.0k 1.3× 124 0.3× 260 0.7× 69 0.2× 51 3.0k
Paul Horrocks United Kingdom 30 955 0.8× 1.9k 2.3× 283 0.7× 275 0.8× 139 0.4× 68 2.8k
Asif Mohmmed India 26 1.3k 1.0× 977 1.2× 123 0.3× 294 0.8× 111 0.3× 87 2.6k
Thomas Maier Germany 29 1.0k 0.8× 320 0.4× 135 0.4× 676 1.9× 93 0.3× 54 2.7k
Syamal Roy India 35 959 0.8× 2.5k 3.1× 158 0.4× 1.6k 4.3× 404 1.1× 106 3.8k
Kok‐Fai Kong United States 19 1.0k 0.8× 291 0.4× 155 0.4× 146 0.4× 106 0.3× 25 2.1k
Nichollas E. Scott Australia 37 2.4k 1.9× 186 0.2× 150 0.4× 403 1.1× 478 1.3× 132 4.1k

Countries citing papers authored by Angus Bell

Since Specialization
Citations

This map shows the geographic impact of Angus Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angus Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angus Bell more than expected).

Fields of papers citing papers by Angus Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angus Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angus Bell. The network helps show where Angus Bell may publish in the future.

Co-authorship network of co-authors of Angus Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Angus Bell. A scholar is included among the top collaborators of Angus Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angus Bell. Angus Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Randle, Laura E., Michael J. Dascombe, Michael G. B. Drew, et al.. (2018). Synthesis, Structural Determination, and Pharmacology of Putative Dinitroaniline Antimalarials. ChemistrySelect. 3(26). 7572–7580. 6 indexed citations
2.
Allemand, Frédéric, et al.. (2015). Two crystal structures of the FK506-binding domain ofPlasmodium falciparumFKBP35 in complex with rapamycin at high resolution. Acta Crystallographica Section D Biological Crystallography. 71(6). 1319–1327. 12 indexed citations
3.
Boehm, Daniela & Angus Bell. (2014). Simply red: A novel spectrophotometric erythroid proliferation assay as a tool for erythropoiesis and erythrotoxicity studies. Biotechnology Reports. 4. 34–41. 4 indexed citations
4.
Prudêncio, Miguel, et al.. (2013). Antimitotic herbicides bind to an unidentified site on malarial parasite tubulin and block development of liver-stage Plasmodium parasites. Molecular and Biochemical Parasitology. 188(2). 116–127. 20 indexed citations
5.
Marín-Menéndez, Alejandro, Paul Monaghan, & Angus Bell. (2012). A family of cyclophilin-like molecular chaperones in Plasmodium falciparum. Molecular and Biochemical Parasitology. 184(1). 44–47. 21 indexed citations
6.
Bell, Angus & Daniela Boehm. (2012). Anti-disease Therapy for Malaria - ‘Resistance Proof’?. Current Pharmaceutical Design. 19(2). 300–306. 3 indexed citations
7.
Bell, Angus. (2011). Antimalarial Peptides: The Long and the Short of It. Current Pharmaceutical Design. 17(25). 2719–2731. 50 indexed citations
8.
Walsh, John & Angus Bell. (2009). Hybrid Drugs for Malaria. Current Pharmaceutical Design. 15(25). 2970–2985. 132 indexed citations
9.
Wittlin, Sergio, R. Brun, Jacques Chollet, et al.. (2009). Plasmodium berghei ANKA: Selection of resistance to piperaquine and lumefantrine in a mouse model. Experimental Parasitology. 122(3). 196–202. 15 indexed citations
10.
Walsh, John, et al.. (2007). A novel artemisinin–quinine hybrid with potent antimalarial activity. Bioorganic & Medicinal Chemistry Letters. 17(13). 3599–3602. 140 indexed citations
11.
Shen, Meiyu, et al.. (2006). Influence of the Plasmodium falciparum P-glycoprotein homologue 1 (pfmdr1 gene product) on the antimalarial action of cyclosporin. Journal of Antimicrobial Chemotherapy. 59(2). 197–203. 8 indexed citations
12.
Naughton, Julie & Angus Bell. (2006). Studies on cell-cycle synchronization in the asexual erythrocytic stages of Plasmodium falciparum. Parasitology. 134(3). 331–337. 22 indexed citations
13.
Bell, Angus, Paul Monaghan, & Antony P. Page. (2005). Peptidyl-prolyl cis–trans isomerases (immunophilins) and their roles in parasite biochemistry, host–parasite interaction and antiparasitic drug action. International Journal for Parasitology. 36(3). 261–276. 101 indexed citations
14.
Bell, Angus. (2005). Antimalarial drug synergism and antagonism: Mechanistic and clinical significance. FEMS Microbiology Letters. 253(2). 171–184. 90 indexed citations
15.
Monaghan, Paul & Angus Bell. (2004). A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl–prolyl cis–trans isomerase and chaperone activities. Molecular and Biochemical Parasitology. 139(2). 185–195. 52 indexed citations
16.
Curley, G. Paul, et al.. (1998). Plasmodium chabaudi chabaudi and P. falciparum  : inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin. Parasitology Research. 84(7). 552–558. 68 indexed citations
17.
Bell, Angus, et al.. (1995). Expression and secretion of malarial parasite β-tubulin in Bacillus brevis. Biochimie. 77(4). 256–261. 9 indexed citations
18.
Bell, Angus, et al.. (1994). Purification of Biologically Active SPARC Expressed in Saccharomyces cerevisiae. Archives of Biochemistry and Biophysics. 314(1). 50–63. 10 indexed citations
19.
Bell, Angus, et al.. (1994). Roles of peptidyl-prolyl CIS-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin a, FK506, and rapamycin. Biochemical Pharmacology. 48(3). 495–503. 100 indexed citations
20.
Bell, Angus, et al.. (1993). Effects of microtubule inhibitors on protein synthesis inPlasmodium falciparum. Parasitology Research. 79(2). 146–152. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026